SEC Form 4 · accession 0001179110-18-001607
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A. Sherman
Officer — President and CEO · Director
Period of report
Feb 2, 2018
Accepted (ET)
Feb 6, 2018 · 12:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2018 | M | 5,453 | $3.06 | A | 338,564 | D | |
| Common Stock | holding | — | — | — | 19,919 | I | By Sherman Investors, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.06 | Feb 2, 2018 | M | 5,453 | D | — | Feb 12, 2018 | Common Stock | 5,453 | 0 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.